Acute Febrile Illness

Acute febrile illness (scrub typhus, leptospirosis, haemorrhagic fever with renal syndrome, murine typhus) are rapidly spreading in the world. These infections occur in Korea (around 100,000 people per year), Southeast Asia and China, causing epidemics particularly in autumn. More than 10 million people are estimated to be infected worldwide annually. The main victims of these infections are people dwelling in the wilds, such as farmers, soldiers, and hikers.
Because of conventional Diagnostic limitations, the mortality rate due to prolonged fever of AFI has been increasing worldwide. Since a different treatment should be applied to each disease, the rapid and accurate Diagnostic is very important to distinguish a certain disease from various ones with similar symptoms. It is currently impossible to differentiate each disease clinically. Therefore, it is necessary to develop specific and sensitive serological Diagnostic.

Development of Diagnostic Kit

ImmuneMed Inc. has focused on developing a rapid, accurate and reproducible acute febrile illness diagnostic kit with high sensitivity and specificity for the past 10 years. We are ready to announce a new AFI rapid kit that simultaneously detects both IgM and IgG of 3 different AFI within 10 minutes based on the lateral flow Immuno Chromatographic Assay. The Diagnostic Kit was developed and met with the world class research standard. We expect that it will be marketed from 2009.

It can potentially be in general hospitals, clinical inspection centers, rural health centers and military clinics worldwide. We also posses the proprietary materials and technologies required for vaccine development and we are sure to develop it soon.

Candidates for Murine Typhus and Tsutsugamushi Deseases

The source materials for vaccine development are confidential.

Features and Benefits of Diagnostic Kit

  • Possess technology to distinguish individual acute febrile illnesses (scrub typhus, leptospirosis,
    haemorrhagic fever with renal syndrome, murine typhus) simultaneously within 10 minutes.
  • Confirmation of IgM and IgG at the same time.
  • Overcoming current limitation of low sensitivity and specificity.
  • Simultaneous detection of major AFI at once, instead of using each separate AFI Diagnostic kit.
  • Huge demands from Southeast Asian countries and China.